12/10/2020, 11:40 PM (Source: TeleTrader)
more TeleTrader news

FDA panel recommends Pfizer's COVID-19 vaccine approval

United States Food and Drug Administration (FDA) panel on Thursday recommended for Pfizer and BioNTech's coronavirus vaccine candidate to be given emergency use authorization (EUA) in the US.

The advisory panel determined that benefits outweigh the known risks about the vaccine and endorsed the candidate's usage in adults over 16 years of age, with a 17-4 vote.

The Vaccines and related biological products advisory board giving the candidate a go-ahead signals the final step before the agency decides whether to approve the distribution of first doses across the country.

Baha Breaking the News (BBN) / BU / NL